MIRAE ASSET SECURITIES (USA) INC.’s Regeneron Pharmaceuticals REGN Stock Holding History

MIRAE ASSET SECURITIES (USA) INC.’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,013	Closed	-$2.63M	–	222
2025 Q2	$2.63M	Buy	5,013 +200	+4%	+$112K	0.08%	147
2025 Q1	$3.05M	Buy	4,813 +1	+0%	+$688	0.08%	134
2024 Q4	$3.43M	Buy	4,812 +1,012	+27%	+$849K	0.1%	96
2024 Q3	$3.99M	Buy	3,800 +1,600	+73%	+$1.78M	0.16%	95
2024 Q2	$2.31M	Buy	+2,200	New	+$2.13M	0.11%	124

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MIRAE ASSET SECURITIES (USA) INC.'s REGN Position: Q3 2025 in Review

MIRAE ASSET SECURITIES (USA) INC. sold out of Regeneron Pharmaceuticals (REGN) in Q3 2025, closing a stake of 5,013 shares — an estimated $2.63M sold.

MIRAE ASSET SECURITIES (USA) INC. first reported a position in REGN in Q2 2024 and held it in 5 quarters. The position peaked at $3.99M in Q3 2024. 1,246 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

MIRAE ASSET SECURITIES (USA) INC. reported no remaining Regeneron Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
MIRAE ASSET SECURITIES (USA) INC. sold 5,013 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $2.63M.
MIRAE ASSET SECURITIES (USA) INC. first reported a position in Regeneron Pharmaceuticals in Q2 2024 and held it in 5 quarters.
MIRAE ASSET SECURITIES (USA) INC.'s Regeneron Pharmaceuticals position peaked at $3.99M in Q3 2024.
1,246 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on MIRAE ASSET SECURITIES (USA) INC.'s 13F filing for Q3 2025, filed 24 Oct 2025.